O
22
2
AKAM
50
7
AIV
70
2
AEP
53
2
PCAR
56
3
ISRG
76
2
MTB
65
2
PSA
56
5
CSX
57
6
RL
68
3
SO
57
2
ORLY
60
7
AMP
73
4
KMI
69
2
EMN
56
7
SWK
61
5
NKE
30
2
MMC
60
6
DVN
18
2
DRI
48
3
O
22
2
AKAM
50
7
AIV
70
2
AEP
53
2
PCAR
56
3
ISRG
76
2
MTB
65
2
PSA
56
5
CSX
57
6
RL
68
3
SO
57
2
ORLY
60
7
AMP
73
4
KMI
69
2
EMN
56
7
SWK
61
5
NKE
30
2
MMC
60
6
DVN
18
2
DRI
48
3
Financhill
Back

Dynavax Technologies 10K Form

Buy
72

DVAX
Dynavax Technologies

Last Price:
12.38
Seasonality Move:
13.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q DVAX/Dynavax Technologies Quarterly
2023-11-02 10Q DVAX/Dynavax Technologies Quarterly
2023-08-03 10Q DVAX/Dynavax Technologies Quarterly
2023-05-02 10Q DVAX/Dynavax Technologies Quarterly
2022-11-03 10Q DVAX/Dynavax Technologies Quarterly
2022-08-04 10Q DVAX/Dynavax Technologies Quarterly

Receive DVAX News And Ratings

See the #1 stock for the next 7 days that we like better than DVAX

DVAX Financial Statistics

Sales & Book Value

Annual Sales: $232.28M
Cash Flow: $18.12M
Price / Cash Flow: 77.54
Annual Sales: $5.19
Price / Book: 2.38

Profitability

EPS (TTM): 0.13000
Net Income (TTM): $20.48M
Gross Margin: $182.12M
Return on Equity: 3.23%
Return on Assets: 2.03%

Dynavax Technologies Earnings Forecast

Key Dynavax Technologies Financial Ratios

  • The Gross Profit Margin over the past 19 years for DVAX is 78.40%.
  • The Selling, General & Administrative Expenses for DVAX have been equal to 65.84% of Gross Profit Margin.
  • The Research & Development expenses have been 23.63% of Revenue.
  • The Interest Expense is -105.76% of Operating Income.
  • The Net Earning history of DVAX is -2.75% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 17 years.

Dynavax Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DVAX
CUSIP: 268158
Website: dynavax.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 13.23
Quick Ratio: 11.98

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 36.9

DVAX Technical Analysis vs Fundamental Analysis

Buy
72
Dynavax Technologies (DVAX) is a Buy

Is Dynavax Technologies a Buy or a Sell?